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Résumé en
anglais
In the present work, lipid nanocapsules (LNC) for curcumin (CCM) encapsulation have
been developed and optimized. The objective was to increase drug cytotoxicity on 9L
glioma cells and drug bioavailability following intravenous administration (IV). Using
the phase inversion technique, we obtained 50 nm LNC loaded with CCM (4 and
6 mg/mL) and, due to the hydrophobic nature of the drug, the encapsulation efficiency
was very high, being around 90%. Following 48 h of incubation with 9L cells, CCM-
loaded LNC were able to reduce the viability of glioma cells resulting in significant
twofold lower IC50 in comparison with the free drug solution. Moreover, CCM-loaded
LNC induced both the apoptosis of 9L cells and a strong release of ATP. This suggests
a cellular uptake of the LNC and an enhanced anti-proliferative effect. In order to
evaluate any alteration in the pharmacokinetic behavior of the encapsulated drug,
CCM-loaded LNC were injected IV into healthy rats, at a dose of 10 mg/kg. CCM
pharmacokinetic studies were carried out quantifying the CCM concentration from the
blood of rats, receiving either CCM-loaded LNC or free CCM solution as a control. The
results demonstrated that loaded LNC exhibited a significantly higher AUC, C and t in
comparison with the control, while the clearance was strongly reduced. Globally, these
results encouraged the use of CCM-loaded LNC to enhance the in vivo therapeutic
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